skip to navigation skip to content
 

Associates

Back to People

Our associates offer expertise in a wide-range of professional and academic disciplines. As leaders in their field, they provide specialised knowledge and support for our startups in the form of workshops, lectures, seminars and one-to-ones. 

Interested in becoming an Associate on the Accelerate Cambridge programme? Sign up online 

Monique Boddington

Monique Boddington

Bio

Monique leads the EVER project which is a longitudinal qualitative study of the teams within Accelerator Cambridge. This project aims to understand the strategic decision making of early ventures and how teams pivot over time. 

Monique is constantly intrigued by understanding the deeper underlying processes behind the way things are. For this reason she has spent the last few years understanding the impact of entrepreneurship education and the role of gender on entrepreneurial practice. Her original background was within Archaeology and after a number of years of spending summers excavating and the completion of a PhD at University of Cambridge, she took the opportunity to change fields and apply her unique insights to the field of entrepreneurship. Alongside her research, Monique is also a tutor and teaching associate on the Postgraduate Diploma in entrepreneurship. When she is not working, Monique is either cycling on the road or on the polo court. 

Clare Dewhurst

Clare Dewhurst

Bio

Clare Dewhurst is Brand Protection Manager for the University of Cambridge.

Her early career was with the Seagram Spirits and Wine Group working in global marketing to protect premium spirits brands from trade mark infringement, counterfeit and grey market trading.  

Prior to coming to the University she worked for a local start up, a strategic communications consultancy specialising in small business policy.  In their first year they won the contract to manage the SME Assembly and European Enterprise Promotion Awards for the European Commission.

Darren Disley

Darrin Disley

Bio

Darrin Disley is a parallel entrepreneur, angel investor and enterprise champion. He is currently CEO of Horizon Discovery Group a company he has led from a $150,000 seed funding in March 2008 to a record $113 million IPO on AIM six years later and a current market capitalisation of over $500 million. He has been involved in the startup and growth of numerous business ventures securing over $425 million business financing as well as closing over $585 million of commercial deals. In 2012, he was named Business Leader of the Year at the European Life Science Awards, in 2014 Global Executive of the Year by Scrip, in 2015 was named UK Quoted Company Entrepreneur of the Year, Cambridge Business Person of the Year, one of the 175 Faces of Chemistry by the Royal Society of Chemistry and in 2017 he was named UK Public Company. CEO of the Year at the Biotech and Money Awards Darrin supports education, entrepreneurship and mentoring programs in the UK via the Professor Christopher R Lowe Carpe Diem Enterprise Fund and has backed over 30 startup life science, technology and social enterprises. This led to him recently being conferred with a lifetime-held Queens Award for Enterprise Promotion in the 2016 birthday honours list. He is an Honorary Fellow at Cambridge Judge Business School and Enterprise Fellow at the Department of Chemical Engineering and Institute of Biotechnology both at the University of Cambridge and an Honorary Visiting Fellow at the University of Salford. He is currently Director and co-founder of Avvinity Therapeutics and GeoSpock, Chairman of Desktop Genetics, Director of Celixir and HealX, Board Member of the UK Bioindustry Association, Chairman of Trustees at Footprint Cafes CIO and serves on the advisory boards of Axol Bioscience, Biotech and Money, the Cambridge Science Centre, the Cambridge Phenomenon, Elpis Biomedical and SimPrints.

Ann Doberee

Anne Dobrée

Bio

Anne has worked in University technology commercialisation since 1999. Anne first joined the technology transfer team at the University of Cambridge in 2001, and has held a number of roles with Cambridge Enterprise and its predecessors including Head of Technology Transfer and Interim Director.

Anne joined the Seed Funds team in 2008 and was appointed Head of Seed Funds in 2011. During her time at CE, Anne has supported many early stage companies and served on the boards of Pneumacare, Cambridge CMOS Sensors, Aqdot and Cambridge Touch Technologies to name a few. Anne was a founding member of Praxis, the UK Technology Transfer Training Programme.

Away from Cambridge Enterprise, Anne has worked in technology transfer at Imperial College Innovations Limited, in pharmaceutical development at Evans Medical, and in pharmaceutical product training at Information Transfer. Anne holds a BSc in Medical Microbiology and a PhD in Immunology.

Richard Green

Richard Green

Bio

Richard Green is passionate about innovation and helping teams to turn disruptive ideas into market leading products and sustainable businesses. A founder and CEO of award winning Ubisense the world leader in Real Time Location Systems, listed on the LSE in 2011 under Richard’s leadership. Richard was a founder of Smallworld, an enterprise geospatial software company which listed on Nasdaq in 1996 and was acquired in a trade sale by GE in 2000. Richard is a Chartered Engineer, Fellow of the Institution of Mechanical Engineers and was Ernst & Young Entrepreneur of the Year 2010 Science and Technology winner. Under Richard’s leadership Ubisense was awarded multiple DTI grants, featured multiple times in the Deloitte Fast50, and was awarded both the Queen’s award for Export and Innovation. In 2011 Ubisense was technology IPO of the year, and won Business Weekly International trade award in 2013.  

Richard is engaged with early stage companies as mentor, consultant and non-executive principally in the Location, IoT, and Mobility space.

Claire Johnsen

Claire Johnsen

Bio

Claire Johnsen is an innovation specialist helping teams with ideation, being alert to trends, futures thinking, developing a value proposition which not only meets the existing, but also the future needs of their clients. Claire works as a member of the consultancy team at  St John’s Innovation Centre, Cambridge.

Andrew Lynn

Andrew Lynn

Bio

Andrew Lynn is an entrepreneur and executive with a focus on life-science and physical-science ventures. Since 2014 he has served as Chief Executive Officer of Fluidic Analytics, a VC-backed biotech developing transformational products for understanding biology in real-time in lab, clinical and digital-health applications. He previously led Orthomimetics (an orthopaedics and regenerative-medicine venture) and CamGaN (a high-bright LED venture) as CEO from founding to exit.

Andrew currently holds appointments as a member of the UK Medical Research Council's Regenerative Medicine Programme Board, an Associate in Entrepreneurship at Cambridge Judge Business School and a Board member of Cambridge Network and Paragraf, amongst others.

His efforts have earned him recognition in Europe as an inaugural winner of a Science Business Academic Enterprise Award and in the US as a member of Technology Review Magazine's TR35 list of the world's top young innovators, leaders and entrepreneurs.

Andrew’s lecture: ‘Business innovation in Science and Technology’

Lucy Malby

Lucy Malby

Bio

Lucy Malby is the Business Manager for Rossdales LLP, one of the largest equine veterinary practices in Europe. Lucy is responsible for managing the non-clinical and business aspects of the partnership, which includes more than 150 people including 50 vets. Rossdales is a respected leader in continuing professional development and research. The practice offers world recognised first-class equine veterinary services to all market sectors including racing, stud, leisure and sports horses.

Lucy has a BSc in Biochemistry and is an Associate of King's College London. Having started her career in clinical research immunoassay design and automation she has significant experience in product design and development in the medtec, biotech and precision electro-mechanical market. 

Lucy has a strong track record in the whole development process having worked in systems engineering, customer acceptance management, production line management, R&D project management and business development.

Pawl Piotrowicz

Pawel Piotrowicz

Bio

Pawel is a UK and European patent attorney and has nearly 20 years' experience advising on intellectual property.  He represents a wide variety of clients in the high technology sector including a significant number of start-up companies and firms based in and around Cambridge.

Pawel specialises in the fields of physics, electronics and computer software, and also in inventions which are multi-disciplinary in nature. His areas of expertise include semiconductor devices, embedded systems, power electronics, automotive electronics, nanotechnology, spintronics, printed electronics, RFID devices, telecommunications, computer networks, computer simulation, optical systems, sensors and medical devices.

In 2006, he took the lead in opening Venner Shipley’s office in Cambridge.

Pawel has been specifically singled out for recommendation in the past in the Legal 500 Directory which described him as "knowledgeable" and "hardworking". He was also commended in the 2015 edition of the Legal 500 Directory.

Tom Phillips

Tom Phillips

Bio

Tom trained in the corporate tax department of KPMG Cambridge, working on a broad range of clients from VC-backed technology companies up to multinationals. He moved over to KPMG Enterprise in 2015 to focus exclusively on startups and fast-growing technology companies, helping them with a range of tax work (including EIS and R&D tax relief) and helping them with other business concerns.  He works closely with KPMG’s High Growth Technology Group, a team based in Shoreditch working exclusively with tech startups, to help bridge the gap between Cambridge and London. 

Tim Rea

Tim Rea

Bio

Tim Rea maintains a portfolio projects related to investment and new business creation. He started his career with British Telecom where he worked on the development of novel optical materials for opto-electronic applications, went on to found a software start-up and from there moved into the Venture Capital industry with Softbank. Over the past 20 years Tim’s portfolio has included a mix of work across the full investment value chain including the management and allocation of capital into VC funds, VC investments, direct, and sometimes operational work with early stage companies, and both the buy and sell side of the exit process. He is an advisor to several investors and over the past 15 years has been a Director of ePlanet Ventures, a global Venture Capital fund where he has been a party to over 100 investments in the US, Europe and Asia including prominent success cases such as Skype and Baidu. He serves on a number of boards where he often takes oversight of financing strategy and engagement with investors.

Hitesh Sanganee

Hitesh Sanganee

AstraZeneca mentor - Director of Emerging Innovations

Bio

Dr Hitesh Sanganee is currently a Director in the Emerging Innovations group. His main role is to participate and execute the open innovation strategy within the innovative medicines function in AZ. This involves collaborating with academic institutions such as MRC (UK) NIH (US) to identify novel uses for our medicines and hence build a portfolio of projects. He has also been involved in internal ideation events (open innovation within a large company setting) in AZ.

Previously his role was in the science function within AstraZeneca. His main role was as a chemistry cluster lead inputting into external and internal drug repositioning projects and potential in-licensing projects. Other roles also have included CDL (candidate drug leader) working on regenerative medicine, and a Team Leader in the respiratory & inflammation therapeutic area. He originally received his degree and DPhil from Oxford University in chemistry and subsequently held a postdoctoral research position at Florida State University. He joined AstraZeneca as a Medicinal Chemist in 1999 conducting research within respiratory & inflammation related disease areas and has led teams to successful milestone transitions in all phases of drug discovery. He has over 40 patents and publications.

Alex Smeets

Alex Smeets

Bio

Dr Alex Smeets runs his own innovation and R&D grant funding consultancy business, providing services to entrepreneurs, small businesses and universities under the brand names of Cambridge Innovation Solutions and Cambridge Funding Solutions. His perspective on grant funding is informed by his role as an evaluator of grant applications for Innovate UK (formerly the UK Technology Strategy Board), the European Commission and the EUREKA Eurostars Secretariat.

Alex is an Associate of Cambridge Enterprise, the commercialisation company of the University of Cambridge, for whom he helps to deliver its International Outreach Programme; consultancy, training, mentoring and visit programmes for universities and public sector organisations from all over the world that want to learn lessons from the Cambridge Phenomenon. He is also an Associate of St John's Innovation Centre, a world-renowned centre that provides flexible accommodation and a supportive environment to early-stage, knowledge-based businesses, and is a registered and approved Growth Coach for the UK-wide GrowthAccelerator service.

In previous lives, Alex was a Regional Director of Oxford Innovation and an Executive Director of St John's Innovation Centre in Cambridge. He has a PhD in Materials Science from the University of Cambridge and worked in materials research and development for five years before branching out into the support of innovation, entrepreneurship and the commercialisation of new knowledge.

Jeremy Sosabowski

Jeremy Sosabowski

Bio

Jeremy has over a decade of business and technology commercialisation experience. His previous roles include CTO at an instrumentation company (technology acquired) and data analyst within the online transaction space. His ‘IP portfolio’ includes several granted patents and more than ten peer reviewed publications. Education: University of Cambridge Engineering PhD and Signal Processing MSc from University of Bristol.

Gordon Soutar

Gordon Soutar

Bio

Gordon is a management consultant, facilitator and entrepreneur with over 30 years experience, the last 17 with his own business, InoSens. He has worked across a broad range of industries, working with teams, to deliver innovative and practical solutions to thorny business challenges. Particular interests lie in business model and value proposition design and implementation. Gordon lives in Cambridge with his wife, two kids and three guitars.

Katy Tuncer

Katy Tuncer

Bio

Katy Tuncer has devoted her career, since joining the British Army 20 years ago, to discovering and examining what works in leadership. She is a Cambridge Natural Sciences graduate, serial entrepreneur, and former McKinsey consultant. She has led transformations in hugely diverse organisations – as an executive, a board member, an advisor and a founder.

Katy coaches senior leaders both sides of the deal (Founders, CEOs, Boards, VCs, Angels) in the Cambridge ecosystem. She is an APECS accredited senior business coach, with rich personal insight from having innovated, failed, succeeded, and challenged convention in leadership.